Anti-Rt CD28 FITC

Anti-Rt CD28 FITC

• CAS Number: 9007-83-4
• Clone: JJ319
• Format: FITC
• Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
• References & Citations: *Haspot F, Villemain F, Laflamme G, Coulon F, Olive D, Tiollier J, Soulillou JP, Vanhove B: Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses. Blood. 2002 Mar 1599(6):2228-34., URL: http://www.ncbi.nlm.nih.gov/pubmed/11877302 ,*Laskowski IA, Pratschke J, Wilhelm MJ, Dong VM, Beato F, Taal M, Gasser M, Hancock WW, Sayegh MH, Tilney NL: Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol. 2002 Feb13(2):519-27., URL: http://www.ncbi.nlm.nih.gov/pubmed/11805183 ,*van den Brandt J, Wang D, Reichardt HM: Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. Mol Endocrinol. 2004 Mar18(3):687-95., URL: http://www.ncbi.nlm.nih.gov/pubmed/14701943 ,*Kerstan A, Armbruster N, Leverkus M, Hünig T: Cyclosporin A abolishes CD28-mediated resistance to CD95-induced apoptosis via superinduction of caspase-3. J Immunol. 2006 Dec 1177(11):7689-97., URL: http://www.ncbi.nlm.nih.gov/pubmed/17114439 ,*Guillonneau C, Séveno C, Dugast AS, Li XL, Renaudin K, Haspot F, Usal C, Veziers J, Anegon I, Vanhove B: Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol. 2007 Dec 15179(12):8164-71., URL: http://www.ncbi.nlm.nih.gov/pubmed/18056359 ,*Dengler TJ, Szabo G, Sido B, Nottmeyer W, Zimmerman R, Vahl CF, Hünig T, Meuer SC: Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Transplantation. 1999 Feb 1567(3):392-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/10030284 ,*Lühder F, Huang Y, Dennehy KM, Guntermann C, Müller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hünig T: Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J Exp Med. 2003 Apr 21197(8):955-66., URL: http://www.ncbi.nlm.nih.gov/pubmed/12707299 ,*Tacke M, Hanke G, Hanke T, Hünig T: CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur J Immunol. 1997 Jan27(1):239-47., URL: https://www.ncbi.nlm.nih.gov/pubmed/9022025,*Robinson LE, Clandinin MT, Field CJ: R3230AC rat mammary tumor and dietary long-chain (n-3) fatty acids change immune cell composition and function during mitogen activation. J Nutr. 2001 Jul131(7):2021-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/11435524,